| Name | Title | Contact Details |
|---|
True Lacrosse is a sports organization founded in 2008 by professional lacrosse players Jake Deane and Mike Gabel, based in Lombard, Illinois. The organization is dedicated to educating and developing young men and women in lacrosse, focusing on creating exceptional athletes while fostering confidence, integrity, and leadership skills. Operating in multiple U.S. states, including Illinois, Colorado, and Michigan, True Lacrosse serves youth players nationwide. The organization emphasizes four core pillars: Passion, Energy, Expertise, and Reps, which guide their training and player development approach. True Lacrosse offers comprehensive training programs that enhance lacrosse skills, game understanding, and athleticism. Their experienced coaching staff, comprised of former professional players, provides valuable insights and support to help players reach their potential and pursue collegiate opportunities. Additionally, True Lacrosse prioritizes player safety by partnering with platforms like HEADCHECK Health to manage concussion risks.
American Business Development Corporation (ABD) helps B2B service providers build scalable, high-impact business development (BD) operations. We specialize in structuring BD strategies, aligning marketing and outreach efforts, and securing key partnerships to drive growth. Whether through a customized Business Development Plan®, implementing BD processes, or serving as an outsourced BD team, ABD ensures companies have the tools, strategy, and execution needed to expand their client pipeline and increase revenue. ABD was founded on the belief that business development is built on relationships, not automation. We dont rely on spam emails or impersonal outreach. Instead, we focus on strategic engagement, tailored messaging, and real human connections to generate high-quality leads and long-term partnerships. Our expertise spans industries such as life sciences, medical devices, professional services, and international trade, helping companies break into new markets and optimize BD functions. For companies expanding into the U.S. market, ABD provides outsourced BD solutions, acting as a dedicated U.S.-based BD team. We represent companies at key industry conferences, execute outreach on partnering platforms, conduct meetings, and manage post-conference follow-up—ensuring that warm, engaged leads are seamlessly transferred to the clients internal team. This eliminates costly international travel while maximizing business development opportunities. ABD also supports export strategies, helping companies expand into foreign markets through strategic partnerships, trade mission planning, and regulatory alignment. With over 20 years of international economic development experience, we connect businesses with high-value clients and funding opportunities through government agencies, accelerators, and industry leaders. At ABD, we dont just generate leads—we build long-term, sustainable BD operations that drive growth beyond our engagement.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Nexus is dedicated to providing the highest quality of service in the field of utilization review. We specialize in providing physician services to the utilization review and risk management industry through accurate, independent, evidence-based results which provide a high quality outcome. Our experienced physicians and professional administrative staff consistently prove to be a leader and beacon for the medical review industry.
Alliance Machine Systems International LLC is the global source of innovative products and services to enhance the efficiency and performance of the corrugated packaging industry. The company continuously strives to provide customers with an ever-broadening line of products and services through investments in R&D, training, strategic acquisitions and partnerships. For more than 40 years, Spokane Valley, Washington-based Alliance has designed and manufactured more than 14,000 machines for the corrugated industry, with installations worldwide. Alliance offers material handling systems that keep pace with todays faster finishing machines. It offers high-speed feeding and downstream handling designs that are reliable, cost-effective solutions to increasing productivity. Products include robotic loadformers, stackers, prefeeders, pallet handlers, specialty folder gluers, and more.